🚀 VC round data is live in beta, check it out!
Rhoen Klinikum Valuation Multiples
Discover revenue and EBITDA valuation multiples for Rhoen Klinikum and similar public comparables like Clinica Baviera, Saudi German Health, HCG Hospitals, Spire Healthcare Group and more.
Rhoen Klinikum Overview
About Rhoen Klinikum
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
Founded
1973
HQ
Employees
18.7K
Website
Sectors
Financials (LTM)
EV
$644M
Rhoen Klinikum Financials
Rhoen Klinikum reported last 12-month revenue of $2B and EBITDA of $129M.
In the same LTM period, Rhoen Klinikum generated $129M in EBITDA and $43M in net income.
Revenue (LTM)
Rhoen Klinikum P&L
In the most recent fiscal year, Rhoen Klinikum reported revenue of $2B and EBITDA of $144M.
Rhoen Klinikum expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $202M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 11% | XXX | XXX | XXX |
| EBITDA | $129M | XXX | $144M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | $43M | XXX | $51M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 3% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Rhoen Klinikum Stock Performance
Rhoen Klinikum has current market cap of $970M, and enterprise value of $644M.
Market Cap Evolution
Rhoen Klinikum's stock price is $14.49.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $644M | $970M | -1.0% | XXX | XXX | XXX | $0.76 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRhoen Klinikum Valuation Multiples
Rhoen Klinikum trades at 0.3x EV/Revenue multiple, and 5.0x EV/EBITDA.
EV / Revenue (LTM)
Rhoen Klinikum Financial Valuation Multiples
As of April 18, 2026, Rhoen Klinikum has market cap of $970M and EV of $644M.
Equity research analysts estimate Rhoen Klinikum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Rhoen Klinikum has a P/E ratio of 22.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $970M | XXX | $970M | XXX | XXX | XXX |
| EV (current) | $644M | XXX | $644M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 5.0x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBIT | 12.6x | XXX | 14.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.2x | XXX | XXX | XXX |
| P/E | 22.7x | XXX | 19.0x | XXX | XXX | XXX |
| EV/FCF | 31.3x | XXX | 9.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Rhoen Klinikum Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Rhoen Klinikum Margins & Growth Rates
Rhoen Klinikum's revenue in the last 12 month grew by 7%.
Rhoen Klinikum's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Rhoen Klinikum's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Rhoen Klinikum's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Rhoen Klinikum Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | (15%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Rhoen Klinikum Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Rhoen Klinikum | XXX | XXX | XXX | XXX | XXX | XXX |
| Clinica Baviera | XXX | XXX | XXX | XXX | XXX | XXX |
| Saudi German Health | XXX | XXX | XXX | XXX | XXX | XXX |
| HCG Hospitals | XXX | XXX | XXX | XXX | XXX | XXX |
| Spire Healthcare Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Pennant Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Rhoen Klinikum M&A Activity
Rhoen Klinikum acquired XXX companies to date.
Last acquisition by Rhoen Klinikum was on XXXXXXXX, XXXXX. Rhoen Klinikum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Rhoen Klinikum
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRhoen Klinikum Investment Activity
Rhoen Klinikum invested in XXX companies to date.
Rhoen Klinikum made its latest investment on XXXXXXXX, XXXXX. Rhoen Klinikum invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Rhoen Klinikum
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Rhoen Klinikum
| When was Rhoen Klinikum founded? | Rhoen Klinikum was founded in 1973. |
| Where is Rhoen Klinikum headquartered? | Rhoen Klinikum is headquartered in Germany. |
| How many employees does Rhoen Klinikum have? | As of today, Rhoen Klinikum has over 18K employees. |
| Is Rhoen Klinikum publicly listed? | Yes, Rhoen Klinikum is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Rhoen Klinikum? | Rhoen Klinikum trades under RHK ticker. |
| When did Rhoen Klinikum go public? | Rhoen Klinikum went public in 1989. |
| Who are competitors of Rhoen Klinikum? | Rhoen Klinikum main competitors are Clinica Baviera, Saudi German Health, HCG Hospitals, Spire Healthcare Group. |
| What is the current market cap of Rhoen Klinikum? | Rhoen Klinikum's current market cap is $970M. |
| What is the current revenue of Rhoen Klinikum? | Rhoen Klinikum's last 12 months revenue is $2B. |
| What is the current revenue growth of Rhoen Klinikum? | Rhoen Klinikum revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Rhoen Klinikum? | Current revenue multiple of Rhoen Klinikum is 0.3x. |
| Is Rhoen Klinikum profitable? | Yes, Rhoen Klinikum is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Rhoen Klinikum? | Rhoen Klinikum's last 12 months EBITDA is $129M. |
| What is Rhoen Klinikum's EBITDA margin? | Rhoen Klinikum's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of Rhoen Klinikum? | Current EBITDA multiple of Rhoen Klinikum is 5.0x. |
| What is the current FCF of Rhoen Klinikum? | Rhoen Klinikum's last 12 months FCF is $21M. |
| What is Rhoen Klinikum's FCF margin? | Rhoen Klinikum's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Rhoen Klinikum? | Current FCF multiple of Rhoen Klinikum is 31.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.